SCHEMBL4125030

SCHEMBL4125030

Cc1noc2c(CO)c(OCc3ccc(F)cc3)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
POLB P06746 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
STAT3 P40763 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
ACHE P22303 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 1/20 0.36
BRD4 O60885 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PTGER1 P34995 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PKM P14618 1/20 0.35
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4125614 0.83 LMNA (0.37) LMNAPOLBSMN1; SMN2MAPTSTAT3
SCHEMBL13597386 0.78 PPARD (0.44) MAPTKDM4EALDH1A1
SCHEMBL13596040 0.77 HTT (0.38) LMNAHTTKMT2AMEN1KDM4E
SCHEMBL4125654 0.74 SLC6A4 (0.43) KMT2AMEN1ACHEKDM4E
SCHEMBL4125623 0.73 LMNA (0.37) LMNAPOLBSMN1; SMN2MAPTSTAT3
SCHEMBL4122115 0.71 ACHE (0.42) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL4127394 0.70 ALDH1A1 (0.34) KMT2AMEN1RXFP1KDM4EALDH1A1
SCHEMBL4120003 0.68 KCNA3 (0.31) LMNA
SCHEMBL15058530 0.67 MEN1 (0.58) LMNAPOLBSMN1; SMN2MAPTSTAT3
SCHEMBL13596012 0.66 ALDH1A1 (0.39) LMNAPOLBMAPTHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 LMNA 3162/4885POLB 3780/4885SMN1; SMN2 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.